Physiological Modeling of Responses to Upper Versus Lower Lobe Lung Volume Reduction in Homogeneous Emphysema

نویسندگان

  • Arschang Valipour
  • Mordechai R. Kramer
  • Franz Stanzel
  • Axel Kempa
  • Sherwin Asadi
  • Oren Fruchter
  • Ralf Eberhardt
  • Felix J. Herth
  • Edward P. Ingenito
چکیده

RATIONALE In clinical trials, homogeneous emphysema patients have responded well to upper lobe volume reduction but not lower lobe volume reduction. MATERIALS/METHODS To understand the physiological basis for this observation, a computer model was developed to simulate the effects of upper and lower lobe lung volume reduction on RV/TLC and lung recoil in homogeneous emphysema. RESULTS Patients with homogeneous emphysema received either upper or lower lobe volume reduction therapy based on findings of radionucleotide scintigraphy scanning. CT analysis of lobar volumes showed that patients undergoing upper (n = 18; -265 mL/site) and lower lobe treatment (LLT; n = 11; -217 mL/site) experienced similar reductions in lung volume. However, only upper lobe treatment (ULT) improved FEV(1) (+11.1 ± 14.7 versus -4.4 ± 15.8%) and RV/TLC (-5.4 ± 8.1 versus -2.4 ± 8.6%). Model simulations provided an unexpected explanation for this response. Increases in transpulmonary pressure subsequent to volume reduction increased RV/TLC in upper lobe alveoli, while caudal shifts in airway closure decreased RV/TLC in lower lobe alveoli. ULT, which eliminates apical alveoli with high RV/TLC values, lowers the average RV/TLC of the lung. Conversely, LLT, which eliminates caudal alveoli with low RV/TLC values, has less effect. CONCLUSION LLT in homogeneous emphysema is uniformly less effective than ULT.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Comparing Clinical Outcomes in Upper versus Lower Lobe Endobronchial Valve Treatment in Severe Emphysema.

BACKGROUND Lung volume reduction surgery has been recommended for patients with upper lobe predominant emphysema and was associated with less favorable outcomes in patients with non-upper lobe predominant emphysema. The value of endobronchial valve (EBV) treatment in lower lobe predominant emphysema has not been studied. OBJECTIVES To confirm the equivalence of upper and lower lobe valve trea...

متن کامل

Sequential unilateral lung volume reduction for emphysema - Stretching the benefit

Bronchoscopic Lung Volume Reduction (BLVR) and Surgical Lung Volume Reduction (SLVR) and are two different approaches used to remodel severely emphysematous lungs to improve lung function and quality-of-life. We present a case initially referred for lung transplantation, where sequential left upper lobe BLVR and 7 years later right upper lobe SLVR, providing enduring physiological and functiona...

متن کامل

Treatment beyond inhalers : endoscopic lung volume reduction

printing supported by . Visit Chiesi at Stand D.30 TUESDAY, SEPTEMBER 27TH 2011 patients underwent a second treatment session after 12 weeks in the contralateral upper lobe to complete bilateral therapy. Pulmonary function, functional capacity, and quality of life assessments were performed at 3 and 6 months following treatment. Results: Upper lobe ELS therapy in this cohort (8 male, age 63±6 y...

متن کامل

Effect of fissure integrity on lung volume reduction using a polymer sealant in advanced emphysema.

RATIONALE Interlobar fissure integrity has previously correlated with responsiveness to endobronchial lung volume reduction therapy in patients with advanced emphysema. OBJECTIVE This report summarises the effect of interlobar fissure integrity on responses to treatment with a novel endoscopic tissue sealant (AeriSeal emphysematous lung sealant (ELS)) that collapses hyperinflated lung. METH...

متن کامل

Computed tomography and monitoring of emphysema.

I t is well known that there have been no successful therapeutic interventions for subjects with emphysema. In the 1990s, investigators became very interested in lung volume reduction surgery (LVRS), first described by BRANTIGAN and MUELLER [1] in 1957, as a treatment for severe emphysema. While many sites promoted the use of LVRS for severe emphysema the criteria for the selection of patients,...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:

دوره 3  شماره 

صفحات  -

تاریخ انتشار 2012